AMPD1 Genotypes and Exercise Capacity in McArdle Patients

Abstract

The purpose of this study was to assess if there exists an association between C34T muscle adenosine monophosphate deaminase (AMPD1) genotypes (i.e., normal homyzygotes [CC] vs. heterozygotes [CT]) and directly measured indices of exercise capacity (peak oxygen uptake [V·O_2peak], ventilatory threshold [VT], gross mechanical efficiency [GE], etc.) in 44 Caucasian McArdle patients (23 males, 21 females). All patients performed a graded cycle ergometer test until exhaustion (for V·O_2peak and VT determination) and a 12-min constant-load test at the power output eliciting the VT (for GE determination). We found no significant difference in indices of exercise capacity between CC (n = 18) and CT genotypes (n = 5) in the group of male patients (p > 0.05). In contrast, the V·O₂ at the VT was significantly lower (p < 0.05) in CT (n = 4; 7.9 ± 0.4 ml/kg/min) than in CC female patients (n = 17; 11.0 ± 0.9 ml/kg/min). In summary, heterozigosity for the C34T allele of the AMPD gene is associated with reduced submaximal aerobic capacity in female patients with McArdle disease and might partly account, in this gender, for the variability that exists in the phenotypic manifestation of the disease.

Key words

glycogenosis type V - AMP deaminase - ventilatory threshold - V·O_2peak

References

• 1 Bruno C, Cassandrini D, Martinuzzi A, Toscano A, Moggio M, Morandi L, Servidei S, Mongini T, Angelini C, Musumeci O, Comi G P, Lamperti C, Filosto M, Zara F, Minetti C. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.  Hum Mutat. 2006;  27 718
• 2 Burki N K, Alam M, Lee L-Y. The pulmonary effects of intravenous adenosine in asthmatic subjects.  Respir Res. 2006;  30 (7) 139
• 3 Burki N K, Dale W J, Lee L-Y. Intravenous adenosine and dyspnea in man.  J Appl Physiol. 2005;  98 180-185
• 4 Chavarren J, Calbet J AL. Cycling efficiency and pedalling frequency in road cyclists.  Eur J Appl Physiol. 1999;  80 555-563
• 5 Coleridge J C, Coleridge H M. Afferent vagal C fibre innervation of the lungs and airways and its functional significance.  Rev Physiol Biochem Pharmacol. 1984;  99 1-110
• 6 Engelstein E D, Lerman B B, Somers V K, Rea R F. Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity.  Circulation. 1994;  90 2919-2926
• 7 Gitt A K, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.  Circulation. 2002;  10 3079-3084
• 8 Griffiths T L, Warren S J, Chant A D, Holgate S T. Ventilatory effects of hypoxia and adenosine infusion in patients after bilateral carotid endarterectomy.  Clin Sci. 1990;  78 25-31
• 9 Gross M, Rotzer E, Kolle P, Mortier W, Reichmann H, Goebel H H, Lochmuller H, Pongratz D, Mahnke-Zizelman D K, Sabina R L. G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.  Neuromuscul Disord. 2002;  12 558-565
• 10 Hagberg J M, Coyle E F, Carroll J E, Miller J M, Martin W H, Brooke M H. Exercise hyperventilation in patients with McArdle's disease.  J Appl Physiol. 1982;  52 991-994
• 11 Hagberg J M, King D S, Rogers M A, Mountain S J, Jilka S M, Kohrt W M, Heller S L. Exercise and recovery ventilatory and V·O₂ responses of patients with McArdle's disease.  J Appl Physiol. 1990;  68 1393-1398
• 12 Heller S L, Kaiser K K, Planer G L, Hagberg J M, Brooke M H. McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.  Neurology. 1987;  37 1039-1042
• 13 Koike A M, Hiroe M, Adachi H, Yajima T, Nogami A, Ito H, Takamoto T, Taniguchi K, Marumo F. Anaerobic metabolism as an indicator of aerobic function during exercise in cardiac patients.  J Am Coll Cardiol. 1992;  20 120-126
• 14 Lowenstein J M. Ammonia production in muscle and other tissues: the purine nucleotide cycle.  Physiol Rev. 1972;  52 382-414
• 15 Lucia A, Hoyos J, Santalla A, Earnest C, Chicharro J L. Tour de France vs. Vuelta a España: which is harder?.  Med Sci Sports Exerc. 2003;  35 872-878
• 16 Lucia A, Maté-Muñoz J L, Pérez M, Gutierrez-Rivas E, Foster C, Arenas J. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?.  Muscle Nerve. 2007;  35 125-128
• 17 Martin M A, Rubio J C, Buchbinder J, Fernandez-Hojas R, del Hoyo P, Teijeira S, Gámez J, Navarro C, Fernández J M, Cabello A, Campos Y, Cervera C, Culebras J M, Andreu A L, Fletterick R, Arenas J. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.  Ann Neurol. 2001;  50 574-581
• 18 Martinuzzi A, Sartori E, Fanin M, Nascimbeni A, Valente L, Angelini C, Siciliano G, Mongini T, Tonin P, Tomelleri G, Toscano A, Merlini L, Bindoff L A, Bertelli S. Phenotype modulators in myophosphorylase deficiency.  Ann Neurol. 2003;  53 497-502
• 19 Matsumura N, Nishijima H, Kojima S, Hashimoto F, Minami M, Yasuda H. Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure.  Circulation. 1983;  68 360-367
• 20 Maxwell D L, Fuller R W, Nolop K B, Dixon C M, Hughes J M. Effects of adenosine on ventilatory responses to hypoxia and hypercapnia in humans.  J Appl Physiol. 1986;  61 1762-1766
• 21 McArdle B. Myophaty due to a defect in muscle glycogen breakdown.  Clin Sci. 1951;  10 13-33
• 22 Meyer T, Lucia A, Earnest C P, Kindermann W. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters - theory and application.  Int J Sports Med. 2005;  26 (Suppl 1) S38-S48
• 23 Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes E W. Molecular basis of AMP deaminase deficiency in skeletal muscle.  Proc Natl Acad Sci USA. 1992;  89 6457-6661
• 24 Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2 % of healthy population.  Muscle Nerve. 1995;  18 239-241
• 25 Norman B, Sabina R L, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.  J Appl Physiol. 2001;  91 258-264
• 26 Pérez M, Martin M A, Cañete S, Rubio J C, Fernández-Moreira D, San Juan A F, Gómez-Gallego F, Santiago C, Arenas J, Lucia A. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?.  Int J Sports Med. 2006;  27 429-435
• 27 Pérez M, Martin M A, Rubio J C, Maté-Muñoz J L, Gómez-Gallego F, Foster C, Andreu A L, Arenas J, Lucia A. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising.  Br J Sports Med. 2006;  40 725-726
• 28 Rico-Sanz J, Rankinen T, Joanisse D R, Leon A S, Skinner J S, Wilmore J H, Rao D C, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE family study.  Physiol Genomics. 2003;  14 161-166
• 29 Riley M, Nicholls D P, Nugent A-M, Steele I C, Bell N, Davies P M, Stanford C F, Patterson V H. Respiratory gas exchange and metabolic responses during exercise in McArdle's disease.  J Appl Physiol. 1993;  75 745-754
• 30 Rubio J C, Martin M A, Del hoyo P, Bautista J, Campos Y, Segura D, Navarro C, Ricoy J R, Cabello A, Arenas J. Molecular analysis of Spanish patients with AMP deaminase deficiency.  Muscle Nerve. 2000;  23 1175-1178
• 31 Rubio J C, Nogales-Gadea G, Garcia-Consuegra I, Blázquez A, Cabello A, Lucia A, Andreu A L, Arenas J, Martin M A. A proposed molecular diagnosis flowchart for myophopshorylase deficiency (McArdle disease) in blood samples from Spanish patients.  Hum Mutat. 2007;  28 203-204
• 32 Tarnopolsky M A, Parise G, Gibala M J, Graham T E, Rush J W. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.  J Physiol. 2001;  533 881-889
• 33 Tsujino S, Shanske S, Dimauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease).  N Engl J Med. 1993;  329 241-245
• 34 Vissing J, Haller R G. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.  N Engl J Med. 2003;  349 2503-2509
• 35 Winder W W. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.  J Appl Physiol. 2001;  91 1017-1028